Pure Global
NCT06403527

Ultrasound Guyded Venous Puncture for Safe AF Ablation Procedures

Cardioangiologisches Centrum Bethanien·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Puncture for Safe Atrial Fibrillation Ablation
Drug/Device/Intervention
Ultrasound guided venous access during AF ablation
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Cardioangiologisches Centrum Bethanien
Location
Frankfurt, Germany
Timeline & enrollment
Phase
N/A
Start date
Mar 03, 2024
End date
Dec 03, 2025
Enrollment
1836 participants
Primary outcome

occurrence of venous access site complications

Summary

To assess if ultrasound guided venous puncture reduces the risk for access site complication
 in the contex of atrial fibrillation ablation.

ICD-10 classifications
Paroxysmal atrial fibrillationPersistent atrial fibrillationChronic atrial fibrillationAtrial fibrillation and atrial flutter, unspecifiedDuring aspiration, puncture and other catheterization
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06403527
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06403527 through Pure Global AI's free database. This phase not specified trial is sponsored by Cardioangiologisches Centrum Bethanien and is currently Recruiting. The study focuses on Puncture for Safe Atrial Fibrillation Ablation. Target enrollment is 1836 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.